BioLife Solutions Inc
BLFS24.900USD
-0.510-2.01%
收盘 12/26, 16:00（美东）报价延迟15分钟
1.19B总市值
亏损市盈率 TTM
关于 BioLife Solutions Inc 公司
BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
BioLife Solutions Inc简介
公司代码BLFS
公司名称BioLife Solutions Inc
上市日期Nov 22, 1989
CEODe Greef (Roderick)
员工数量159
证券类型Ordinary Share
年结日Nov 22
公司地址Suite 310
城市BOTHELL
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编98021
电话14254011400
网址https://www.biolifesolutions.com/
公司代码BLFS
上市日期Nov 22, 1989
CEODe Greef (Roderick)
BioLife Solutions Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
252.89K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.11K
-0.28%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
68.75K
-30.38%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
49.99K
-0.43%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
38.11K
-7.30%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
25.93K
-0.42%
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
13.81K
-42.00%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
5.70K
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
252.89K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.11K
-0.28%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
68.75K
-30.38%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
49.99K
-0.43%
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%
由于公司未披露，未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%
股东统计
更新时间: 11月15日 周六
更新时间: 11月15日 周六
持股股东
股东类型
持股股东
持股股东
占比
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.60%
T. Rowe Price Investment Management, Inc.
8.45%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.15%
其他
55.21%
持股股东
持股股东
占比
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.60%
T. Rowe Price Investment Management, Inc.
8.45%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.15%
其他
55.21%
股东类型
持股股东
占比
Investment Advisor
49.20%
Investment Advisor/Hedge Fund
34.12%
Hedge Fund
15.54%
Research Firm
2.32%
Individual Investor
2.00%
Pension Fund
1.60%
Bank and Trust
0.65%
Sovereign Wealth Fund
0.08%
Insurance Company
0.03%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
402
49.86M
109.33%
-743.44K
2025Q3
418
50.60M
112.73%
+431.43K
2025Q2
417
51.14M
109.98%
+2.32M
2025Q1
412
48.78M
108.79%
-2.89M
2024Q4
397
47.68M
109.40%
+879.99K
2024Q3
391
46.15M
113.67%
-1.38M
2024Q2
371
47.55M
108.21%
+1.88M
2024Q1
363
45.48M
113.98%
-6.15M
2023Q4
383
46.46M
115.88%
+36.24K
2023Q3
386
44.68M
106.82%
+2.82M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Casdin Capital, LLC
6.71M
14%
-1.00M
-12.97%
Aug 15, 2025
BlackRock Institutional Trust Company, N.A.
5.08M
10.61%
+12.43K
+0.25%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
4.25M
8.86%
+2.90M
+215.04%
Jun 30, 2025
Invesco Advisers, Inc.
3.46M
7.22%
+126.62K
+3.80%
Jun 30, 2025
The Vanguard Group, Inc.
2.89M
6.03%
+93.13K
+3.33%
Jun 30, 2025
State Street Investment Management (US)
1.41M
2.94%
-24.84K
-1.73%
Jun 30, 2025
Fred Alger Management, LLC
1.25M
2.61%
-285.09K
-18.60%
Jun 30, 2025
MFS Investment Management
1.10M
2.3%
+337.42K
+44.13%
Jun 30, 2025
Rockefeller Capital Management
1.03M
2.14%
+62.16K
+6.45%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco S&P SmallCap Health Care ETF
0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
0.52%
Zacks Small/Mid Cap ETF
0.41%
iShares Micro-Cap ETF
0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
0.15%
First Trust Small Cap Growth AlphaDEX Fund
0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.14%
iShares S&P Small-Cap 600 Growth ETF
0.14%
iShares ESG Select Screened S&P Small-Cap ETF
0.09%
查看更多
Invesco S&P SmallCap Health Care ETF
占比0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
占比0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
占比0.52%
Zacks Small/Mid Cap ETF
占比0.41%
iShares Micro-Cap ETF
占比0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
占比0.15%
First Trust Small Cap Growth AlphaDEX Fund
占比0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
占比0.14%
iShares S&P Small-Cap 600 Growth ETF
占比0.14%
iShares ESG Select Screened S&P Small-Cap ETF
占比0.09%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
BioLife Solutions Inc的前五大股东是谁？
BioLife Solutions Inc 的前五大股东如下：
Casdin Capital, LLC持有股份：6.71M，占总股份比例：14.00%。
BlackRock Institutional Trust Company, N.A.持有股份：5.08M，占总股份比例：10.61%。
T. Rowe Price Investment Management, Inc.持有股份：4.25M，占总股份比例：8.86%。
Invesco Advisers, Inc.持有股份：3.46M，占总股份比例：7.22%。
The Vanguard Group, Inc.持有股份：2.89M，占总股份比例：6.03%。
Casdin Capital, LLC持有股份：6.71M，占总股份比例：14.00%。
BlackRock Institutional Trust Company, N.A.持有股份：5.08M，占总股份比例：10.61%。
T. Rowe Price Investment Management, Inc.持有股份：4.25M，占总股份比例：8.86%。
Invesco Advisers, Inc.持有股份：3.46M，占总股份比例：7.22%。
The Vanguard Group, Inc.持有股份：2.89M，占总股份比例：6.03%。
BioLife Solutions Inc的前三大股东类型是什么？
BioLife Solutions Inc 的前三大股东类型分别是：
Casdin Capital, LLC
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
Casdin Capital, LLC
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.
有多少机构持有BioLife Solutions Inc(BLFS)的股份？
截至2025Q4，共有402家机构持有BioLife Solutions Inc的股份，合计持有的股份价值约为49.86M，占公司总股份的109.33%。与2025Q3相比，机构持股有所增加，增幅为-3.40%。
哪个业务部门对BioLife Solutions Inc的收入贡献最大？
在FY2025Q2，Product Revenue-Cell processing业务部门对BioLife Solutions Inc的收入贡献最大，创收22.90M，占总收入的90.08%。
